Amyloid-β deposition in mild cognitive impairment is associated with increased hippocampal activity, atrophy and clinical progression
Willem Huijbers(Massachusetts General Hospital), Reisa A. Sperling(Harvard University), Sarah Wigman(Brigham and Women's Hospital), Andrew Ward(Brigham and Women's Hospital), Gad A. Marshall, Dorene M. Rentz(Brigham and Women's Hospital), Elizabeth C. Mormino(Allen Institute for Brain Science), Rebecca E. Amariglio(Harvard University), Mykol Larvie(Harvard University), Keith A. Johnson(Brigham and Women's Hospital), Aaron P. Schultz(Harvard University)
Cited by 248
Related Papers
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
|Alzheimer s & Dementia|2011|7.1k
Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
|New England Journal of Medicine|2012|3.8k
A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease
|Alzheimer s & Dementia|2014|3.1k